Literature DB >> 3956523

Felodipine in ventricular dysfunction.

A C Tweddel, I Hutton.   

Abstract

The systemic and coronary haemodynamic effects of felodipine were evaluated at rest and during stress induced atrial pacing in fourteen patients with chronic cardiac failure, secondary to coronary heart disease. Felodipine was an effective arteriolar vasodilator producing increases in cardiac index from 2.6 +/- 0.1 to 3.5 +/- 0.2 l min-1 m-2 (P less than 0.001) and stroke volume 35.3 +/- 2.7 to 41.4 +/- 2.4 ml beat-1 m-2 (P less than 0.002). Coronary venous flow also increased significantly (126 +/- 8 to 168 +/- 13 ml min-1) (P less than 0.005) and this did not appear to be accompanied by an increase in myocardial oxygen usage, as myocardial oxygen consumption was essentially unchanged. When the myocardium was stressed by atrial pacing the increase in cardiac output and stroke volume was maintained--25% and 23%, respectively (P less than 0.01). These results suggest that felodipine may well have a significant role in the management of patients with congestive cardiac failure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956523     DOI: 10.1093/oxfordjournals.eurheartj.a061958

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

Review 1.  Felodipine clinical pharmacokinetics.

Authors:  P H Dunselman; B Edgar
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

2.  Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects.

Authors:  L B Tan; R G Murray; W A Littler
Journal:  Br Heart J       Date:  1987-08

3.  Twenty-four hour profile of the hypotensive action of felodipine in essential hypertension.

Authors:  I G Crozier; H Ikram; M G Nicholls; C J Low
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

4.  Felodipine prevents the poststenotic myocardial ischemia induced by alpha 2-adrenergic coronary constriction.

Authors:  T Ehring; G Heusch
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

Review 5.  Calcium channel antagonists. Part V: Second-generation agents.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

6.  Pharmacokinetics of felodipine and effect on digoxin plasma levels in patients with heart failure.

Authors:  N Rehnqvist; E Billing; L Moberg; T Lundman; G Olsson
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Sustained haemodynamic effects of felodipine in patients with chronic cardiac failure.

Authors:  A C Tweddel; W Martin; A I McGhie; I Hutton
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

8.  Central and peripheral haemodynamic responses to felodipine in congestive heart failure.

Authors:  S Capewell; C G Wathen; A L Muir
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

9.  Felodipine in severe chronic congestive heart failure: acute effects on central hemodynamics and regional blood flow distribution.

Authors:  G Binetti; I Rubino; E Varani; R Spadoni; R M Ferretti; V Cervi; B Magnani
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.